Looking for Sentiment Analysis? Discover the most popular stocks on Reddit by using our Sentiment Tracker
NVS - Novartis AG
Market Cap 166.31B P/E 7.45 EPS this Y -3.00% Ern Qtrly Grth -41.50%
Income 22.98B Forward P/E 11.38 EPS next Y 9.50% 50D Avg Chg -9.00%
Sales 52.79B PEG 3.06 EPS past 5Y 5.71% 200D Avg Chg -11.00%
Dividend 4.00% Price/Book 2.64 EPS next 5Y 4.14% 52W High Chg -19.00%
Recommedations 2.20 Quick Ratio 1.03 Shares Outstanding 2.18B 52W Low Chg 1.00%
Insider Own 0.01% ROA 6.72% Shares Float 2.10B Beta 0.49
Inst Own 9.22% ROE 39.23% Shares Shorted/Prior 5.66M/6.09M Price 76.01
Gross Margin 71.61% Profit Margin 43.54% Avg. Volume 2,150,422 Target Price 102.00
Oper. Margin 25.14% Earnings Date - Volume 2,736,785 Change -1.46%
Healthcare | Drug Manufacturers | Switzerland
Novartis AG News
09/23/22 Ionis' (IONS) Hypercholesterolemia Drug Not to Enter Phase III
09/23/22 Novartis (NVS) to Focus on US Markets Backed by 8 Key Drugs
09/23/22 Novartis outlines plan to become a 'top-five player' in U.S. pharmaceuticals market
09/23/22 Strength Seen in Lilly (LLY): Can Its 4.9% Jump Turn into More Strength?
09/22/22 Novartis (NVS) to Appeal to Supreme Court for Gilenya Patent
09/22/22 Novartis Unveils New Strategy Focused On US-First, Eight Blockbuster Brands
09/22/22 UPDATE 3-Novartis to prioritise U.S. market, unfazed by drug pricing pushback
09/22/22 Novartis to prioritise U.S. market, unfazed by drug pricing pushback
09/22/22 Novartis unveils new focused strategy, underpinned by eight potential multi-billion dollar peak sales brands & deep pipeline, at Meet the Management event
09/21/22 Novartis, Moderna Partner Agrees To Merge With Beleaguered Sesen Bio
09/21/22 3 Highly Profitable Stocks That Are Super Cheap Right Now
09/21/22 Novartis To Petition US Supreme Court To Uphold Patent Validity For Multiple Sclerosis Drug, Gilenya
09/21/22 Novartis Planning to Bring Dispute Over Drug Patent to U.S. Supreme Court
09/21/22 Novartis to take U.S. drug patent case to Supreme Court
09/21/22 Novartis plans to petition the U.S. Supreme Court to uphold validity of the Gilenya® (fingolimod) dosing regimen patent
09/20/22 European Stock Futures Lower; Fed Meeting Firmly in Focus
09/20/22 3 Stocks That Could Rocket on Biden’s Cancer Moonshot
09/20/22 Novartis (NVS) Unit Posts Positive Results on Prolia Biosimilar
09/19/22 The Zacks Analyst Blog Highlights AbbVie, Novartis, Merck and AstraZeneca

Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatology, respiratory, cardiovascular, renal, and metabolism medicine products. The Sandoz segment develops, manufactures, and markets finished dosage form medicines; active ingredients and finished dosage forms of small molecule pharmaceuticals to third parties; and retail generics and anti-infectives. It also provides active pharmaceutical ingredients and intermediates primarily antibiotics; protein- or other biotechnology-based products, including biosimilars; and biotechnology manufacturing services. Novartis AG has a license and collaboration agreement with Alnylam Pharmaceuticals to develop, manufacture, and commercialize inclisiran; and a clinical collaboration with Kura Oncology, Inc. to evaluate the combination of Tipifarnib and Alpelisib in patients with head and neck squamous cell carcinoma. The company was incorporated in 1996 and is headquartered in Basel, Switzerland.

NVS Chatroom

User Image BidaskBot Posted - 7 hours ago

Novartis $NVS BidaskScore is #Reiterated to Sold https://bidaskclub.com/news/company/2022-09-21/NVS

User Image stockilluminati Posted - 8 hours ago

$NVS https://www.stockilluminati.com/nvs/news.php - Start Buying This Week, I Explain, Why And How

User Image tickeron Posted - 20 hours ago

$JNJ vs. $NVS: what is the best stock to add to your portfolio? https://tickeron.com/compare/JNJ-vs-NVS/?utm_source=stocktwits_free&utm_medium=news&utm_campaign=compare_summary

User Image SweepCast Posted - 1 day ago

@SweepCast Unusual Options Observed: $NVS with our scanner on $60 PUT Expiring: 01-19-2024 worth 55K🐻 ⬅️ Use this in real-time with @SweepCast - See Profile for More Info 🏆

User Image Game2021 Posted - 2 days ago

$NVS Time to scale in with long dated calls 🥂

User Image TalkMarkets Posted - 2 days ago

Strength Seen in Lilly (LLY): Can Its 4.9% Jump Turn into More Strength? $LLY Also $NVS https://talkmarkets.com/content/stocks--equities/strength-seen-in-lilly-lly-can-its-49-jump-turn-into-more-strength?post=368900

User Image STCKPRO Posted - 2 days ago

$NVS NEW ARTICLE : Novartis outlines plan to become a 'top-five player' in U.S. pharmaceuticals market https://www.stck.pro/news/NVS/34710542

User Image stockilluminati Posted - 3 days ago

$NVS https://www.stockilluminati.com/nvs/news.php - CryoPort: A Rare Investing Opportunity

User Image spanky45 Posted - 3 days ago

$TSOI Donald Banerji For new investors Let us not forget we brought in Dr. Donald Banerji, he came from Novartis $NVS a company worth hundreds of BILLION dollars. They have 2.5 billion outstanding shares trading at $77. Look it up. He came to $TSOI that has the same amount of outstanding shares but trading at $0.01 worth around 28 million. Why would he do that. Something bigger That like the CEO of Home Depot quitting to come work at the local hardware store. Just think about that must have something going on.

User Image AmberMakesMoney Posted - 3 days ago

$nvs Novartis Announced Focusing Strategy on Five Core Therapeutic Areas, Key Technology Platforms, and U.S.; Said Will Continue to Deliver Improved Financials With +4% Sales CAGR Through 2027 and Core Op Inc Margin ~40%+ in Mid-long Term

User Image briefingcom Posted - 4 days ago

$NVS unveils new focused strategy, underpinned by eight potential multi-billion dollar peak sales brands & deep pipeline https://t.co/p7aZrCkquS

User Image STCKPRO Posted - 4 days ago

$NVS NEW ARTICLE : Novartis to prioritise U.S. market unfazed by drug pricing pushback https://www.stck.pro/news/NVS/34639290

User Image Newsfilter Posted - 4 days ago

$NVS Prospective Observational Study to Identify and Describe Predictive Factors for Thromboembolic Events in Patients With High-risk Polycythemia Vera - NCT05548062 https://newsfilter.io/a/23fef7e159846289b133be08c1548910

User Image quantcha Posted - 4 days ago

52-Week Low Alert: Trading today's movement in NOVARTIS $NVS https://wp.me/p5bLGB-hRMt

User Image briefingcom Posted - 5 days ago

$NVS plans to petition the U.S. Supreme Court to uphold validity of the Gilenya (fingolimod) dosing regimen patent https://t.co/uyPSuaZ9zJ

User Image cctranscripts Posted - 5 days ago

Report of foreign issuer [Rules 13a-16 and 15d-16] https://www.conferencecalltranscripts.com/summary/?id=11318417 $NVS

User Image risenhoover Posted - 5 days ago

$NVS / Novartis files form 6-K https://fintel.io/sf/us/nvs?utm_source=stocktwits.com&utm_medium=Referral&utm_campaign=filing

User Image Quantisnow Posted - 5 days ago

$NVS 📜 SEC Form 6-K filed by Novartis AG https://quantisnow.com/i/3435216?utm_source=stocktwits 45 seconds delayed.

User Image Newsfilter Posted - 5 days ago

$NVS Form 6-K (report of foreign issuer [rules 13a-16 and 15d-16]) filed with the SEC https://newsfilter.io/a/4ee8b80b51895da59aec13971fa9cf6c

User Image STCKPRO Posted - 5 days ago

$NVS NEW ARTICLE : Novartis to take U.S. drug patent case to Supreme Court https://www.stck.pro/news/NVS/34584965

User Image stockilluminati Posted - 5 days ago

$NVS https://www.stockilluminati.com/nvs/news.php - Terns Pharmaceuticals: The Easy Money Has Been Made

User Image dloeb Posted - 5 days ago

$NVS starting position to bottom fish

User Image tickeron Posted - 6 days ago

Looks interesting. Pay attention to these news! $NVS in -0.32% Downtrend, falling for three consecutive days on September 16, 2022. View odds for this and other indicators: https://srnk.us/go/4003339

User Image JonahG1990 Posted - 6 days ago

$NVS

User Image Newsfilter Posted - 6 days ago

$NVS A Trial of NIS793 With FOLFIRINOX in Pancreatic Cancer - NCT05546411 https://newsfilter.io/a/d4f3eab4a3d5555102f9c91b70478916

User Image GreenSharken Posted - 1 week ago

$LABU Big pharma like $PFE , $MRK , $NVS or $LLY have no other option but to use their cash devalued by inflation in new acquisitions....

User Image IntelligentTrading Posted - 1 week ago

$THMO it's very interesting to me that $PFE $NVS $LLY $BMY are all joining together to create a new biotech company specifically for CAR-T therapies. This news was dated Sept 14 2022 so this is fresh info. https://www.biopharmadive.com/news/capstan-launch-mrna-car-t-weissman-june-levine/631835/

User Image stocktradersdaily Posted - 1 week ago

$NVS | Novartis $NVS Investment Report (NVS) https://tinyurl.com/2kscqdjo

User Image SweepCast Posted - 1 week ago

@SweepCast Unusual Options Observed: $NVS with our scanner on $80 PUT Expiring: 10-21-2022 worth 60K🐻 ⬅️ The Flow of Smart Money Options Is Critical - See Profile for More Info 🏆

User Image SweepCast Posted - 1 week ago

@SweepCast Unusual Options Observed: $NVS with our scanner on $82.5 CALL Expiring: 10-21-2022 worth 26K🐂 ⬅️ Use this in real-time with @SweepCast - See Profile for More Info 🏆

Analyst Ratings
Wolfe Research Peer Perform May 9, 22
Exane BNP Paribas Neutral Dec 6, 21
Bryan Garnier Neutral Dec 3, 21
Deutsche Bank Sell Sep 20, 21
Argus Research Hold Mar 10, 21
Cowen & Co. Market Perform Feb 1, 21
Deutsche Bank Buy Jan 15, 21
Morgan Stanley Overweight Sep 1, 20
Guggenheim Securities Neutral Feb 25, 20